While major accomplishments in blood and marrow transplantation (BMT) were
being made around the country, the first BMT
program at Wake Forest Baptist came into view,
a vision brought to life by David D. Hurd, MD.
Determination of BRCA1 and 2 mutation carrier status has become increasingly important. Estimates suggest that about 80% of breast cancers and 90% of ovarian cancers are sporadic; while only 5% to 10% of breast cancers are hereditary.